Clinical, laboratory and histopathological profiles of thyroid carcinoma patients at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia from January 2020 to June 2024

Thyroid carcinoma is a malignancy of the thyroid gland and it is the most common endocrine tumor. Globally, thyroid carcinoma ranks 7th in incidence and 24th in mortality, while in Indonesia, thyroid carcinoma ranks 12th among all carcinomas. Therefore, this study aims to determine the clinical, laboratory, and histopathological profiles of thyroid carcinoma patients. This study used a retrospective descriptive method with total sampling technique. The data were collected from medical records of thyroid carcinoma patients at Dr. Soetomo General Academic Hospital from January 2020 to June 2024. A total of 141 thyroid carcinoma patients were enrolled in this research. Most were aged 51-60 years (34.0%) and female (74.5%). The most commonly reported symptoms were a lump in the neck (100%), hoarseness (19.9%), and pain in the lump (15.6%). Nodules were commonly found to be >4 cm (49.6%), predominantly on the right side of the neck (36.9%). Most patients had normal FT4 (66.0%) and TSH levels (61.7%). Most patients had TR5 ultrasound results (44.7%). The most common histopathological type is papillary (91.5%), and stage 1 (47.5%) is the most common stage. Lymph nodes were the most frequent site of metastasis (36.2%). In conclusion, thyroid carcinoma most commonly occurs in patients aged 51-60 years, predominantly female, and the main complaint is a lump in the neck. Most patients have normal laboratory results and TR5 ultrasound results. The most common type is papillary, at stage 1, with the most common metastasis to lymph nodes.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-12-31
DOI
https://doi.org/10.5281/zenodo.17875638
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical, laboratory and histopathological profiles of thyroid carcinoma patients at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia from January 2020 to June 2024

Zenodo (CERN European Organization for Nuclear Research)
Thyroid Cancer Diagnosis and Treatment
article

Clinical, laboratory and histopathological profiles of thyroid carcinoma patients at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia from January 2020 to June 2024

article en

Abstract

Thyroid carcinoma is a malignancy of the thyroid gland and it is the most common endocrine tumor. Globally, thyroid carcinoma ranks 7th in incidence and 24th in mortality, while in Indonesia, thyroid carcinoma ranks 12th among all carcinomas. Therefore, this study aims to determine the clinical, laboratory, and histopathological profiles of thyroid carcinoma patients. This study used a retrospective descriptive method with total sampling technique. The data were collected from medical records of thyroid carcinoma patients at Dr. Soetomo General Academic Hospital from January 2020 to June 2024. A total of 141 thyroid carcinoma patients were enrolled in this research. Most were aged 51-60 years (34.0%) and female (74.5%). The most commonly reported symptoms were a lump in the neck (100%), hoarseness (19.9%), and pain in the lump (15.6%). Nodules were commonly found to be >4 cm (49.6%), predominantly on the right side of the neck (36.9%). Most patients had normal FT4 (66.0%) and TSH levels (61.7%). Most patients had TR5 ultrasound results (44.7%). The most common histopathological type is papillary (91.5%), and stage 1 (47.5%) is the most common stage. Lymph nodes were the most frequent site of metastasis (36.2%). In conclusion, thyroid carcinoma most commonly occurs in patients aged 51-60 years, predominantly female, and the main complaint is a lump in the neck. Most patients have normal laboratory results and TR5 ultrasound results. The most common type is papillary, at stage 1, with the most common metastasis to lymph nodes.

Zenodo (CERN European Organization for Nuclear Research)
Universitas Airlangga (ID)
Good health and well-being
Openalex Percentile: Top 33%
Thyroid Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Clinical, laboratory and histopathological profiles of thyroid carcinoma patients at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia from January 2020 to June 2024 · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS